Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-04-29 2020-04-29
Drug Identification Number 02451719 02451719
Brand name ARIXTRA ARIXTRA
Common or Proper name Arixtra 0.8 mL single use pre-filled syringe Arixtra 0.8 mL single use pre-filled syringe
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients FONDAPARINUX SODIUM FONDAPARINUX SODIUM
Strength(s) 12.5MG 12.5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10 10
ATC code B01AX B01AX
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2014-01-01 2014-01-01
Estimated end date Unknown Unknown
Actual end date 2014-01-02 2014-01-02
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments n/a n/a
Health Canada comments